Muhammad Alaa Eldeen

711 total citations
41 papers, 520 citations indexed

About

Muhammad Alaa Eldeen is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Muhammad Alaa Eldeen has authored 41 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Muhammad Alaa Eldeen's work include vaccines and immunoinformatics approaches (9 papers), Epigenetics and DNA Methylation (5 papers) and Ferroptosis and cancer prognosis (4 papers). Muhammad Alaa Eldeen is often cited by papers focused on vaccines and immunoinformatics approaches (9 papers), Epigenetics and DNA Methylation (5 papers) and Ferroptosis and cancer prognosis (4 papers). Muhammad Alaa Eldeen collaborates with scholars based in Egypt, Saudi Arabia and Kuwait. Muhammad Alaa Eldeen's co-authors include Refaat A. Eid, Mohamed A. Soltan, Mohamed Samir Ahmed Zaki, Attalla F. El‐kott, Mubarak Al‐Shraim, Ahmed A. Al‐Karmalawy, Eman Fayad, Samy M. Eleawa, Hussain Aldera and Mahmoud A. Alkhateeb and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Biomedicine & Pharmacotherapy.

In The Last Decade

Muhammad Alaa Eldeen

37 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Muhammad Alaa Eldeen Egypt	15	267	78	73	60	50	41	520
Babajan Banaganapalli Saudi Arabia	18	381 1.4×	68 0.9×	57 0.8×	90 1.5×	69 1.4×	60	751
Huihui Guo China	18	315 1.2×	117 1.5×	104 1.4×	60 1.0×	44 0.9×	55	791
Ching-Yen Lin Taiwan	14	223 0.8×	105 1.3×	31 0.4×	35 0.6×	84 1.7×	25	527
Meizhou Huang China	16	233 0.9×	77 1.0×	31 0.4×	59 1.0×	40 0.8×	31	569
Naohisa Tsutsui Japan	11	196 0.7×	71 0.9×	74 1.0×	83 1.4×	51 1.0×	20	531
Nannan Liu China	15	267 1.0×	162 2.1×	64 0.9×	43 0.7×	20 0.4×	48	656
Yinhui Dong China	17	325 1.2×	86 1.1×	56 0.8×	38 0.6×	82 1.6×	25	666
Mengyuan Chen China	16	303 1.1×	141 1.8×	55 0.8×	55 0.9×	117 2.3×	70	820

Countries citing papers authored by Muhammad Alaa Eldeen

Since Specialization

Citations

This map shows the geographic impact of Muhammad Alaa Eldeen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Alaa Eldeen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Alaa Eldeen more than expected).

Fields of papers citing papers by Muhammad Alaa Eldeen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Alaa Eldeen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Alaa Eldeen. The network helps show where Muhammad Alaa Eldeen may publish in the future.

Co-authorship network of co-authors of Muhammad Alaa Eldeen

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Alaa Eldeen. A scholar is included among the top collaborators of Muhammad Alaa Eldeen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Alaa Eldeen. Muhammad Alaa Eldeen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eldeen, Muhammad Alaa, Mostafa Abdelrahman, Dalal Sulaiman Alshaya, et al.. (2025). Oncogenic EME1 promotes tumor progression and immune modulation in human cancers with therapeutic targeting potential. Discover Oncology. 16(1). 1855–1855.

Li, Zesong, et al.. (2024). Computational Design of a Multi-Epitope Vaccine against Prevotella copri: Molecular Dynamics and Immunoinformatics Study. Journal of Computational Biophysics and Chemistry. 24(5). 575–589.

Rehman, Irshad Ur, et al.. (2024). Structural Insights and Drug Repurposing of FDA-Approved Molecules against Human Agmatinase in Cancer Therapy. Journal of Computational Biophysics and Chemistry. 24(6). 767–780. 1 indexed citations

Soltan, Mohamed A., Waleed K. Abdulsahib, Refaat A. Eid, et al.. (2024). Application of Reverse Vaccinology and Immunoinformatics to Design a Multitope Vaccine Against Gastrointestinal Cancer-Inducing Cryptosporidium Parvum. Journal of Computational Biophysics and Chemistry. 24(1). 13–32. 1 indexed citations

Akl, Mohamed A., et al.. (2024). Beyond Skin Deep: Phospholipid-Based Nanovesicles as Game-Changers in Transdermal Drug Delivery. AAPS PharmSciTech. 25(6). 184–184. 14 indexed citations

Eid, Refaat A., Muhammad Alaa Eldeen, Mohamed A. Soltan, et al.. (2023). Integrative analysis of WDR12 as a potential prognostic and immunological biomarker in multiple human tumors. Frontiers in Genetics. 13. 1008502–1008502. 7 indexed citations

Soltan, Mohamed A., Muhammad Alaa Eldeen, Refaat A. Eid, et al.. (2023). A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers. Frontiers in Molecular Biosciences. 10. 1017148–1017148. 9 indexed citations

Soltan, Mohamed A., Muhammad Alaa Eldeen, Reda F. A. Abdelhameed, et al.. (2023). Integration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy. Biology. 12(4). 613–613. 7 indexed citations

Eid, Refaat A., et al.. (2023). Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance. International Journal of Molecular Sciences. 24(2). 1786–1786. 41 indexed citations

10.

Eid, Refaat A., Mohammed Alshehri, Mohamed Samir Ahmed Zaki, et al.. (2023). Unraveling Extremely Damaging IRAK4 Variants and Their Potential Implications for IRAK4 Inhibitor Efficacy. Journal of Personalized Medicine. 13(12). 1648–1648. 2 indexed citations

11.

Eid, Refaat A., Muhammad Alaa Eldeen, Mohamed A. Soltan, et al.. (2023). Integration of Ultrastructural and Computational Approaches Reveals the Protective Effect of Astaxanthin against BPA-Induced Nephrotoxicity. Biomedicines. 11(2). 421–421. 1 indexed citations

12.

Soltan, Mohamed A., Muhammad Alaa Eldeen, Refaat A. Eid, et al.. (2022). Cyanidin-3-Glucoside Modulates hsa_circ_0001345/miRNA106b/ATG16L1 Axis Expression as a Potential Protective Mechanism against Hepatocellular Carcinoma. Current Issues in Molecular Biology. 44(4). 1677–1687. 17 indexed citations

13.

Eid, Refaat A., Mohamed A. Soltan, Muhammad Alaa Eldeen, et al.. (2022). Assessment of RACGAP1 as a Prognostic and Immunological Biomarker in Multiple Human Tumors: A Multiomics Analysis. International Journal of Molecular Sciences. 23(22). 14102–14102. 14 indexed citations

14.

Ullah, Ihsan, Sadia Sattar, Ijaz Ali, et al.. (2022). Molecular Epidemiology of Cystic Echinococcosis in Rural Baluchistan, Pakistan: A Cross-Sectional Study. Pathogens. 12(1). 40–40. 3 indexed citations

15.

Soltan, Mohamed A., Sarah Albogami, Eman Fayad, et al.. (2022). In silico Designing of an Epitope-Based Vaccine Against Common E. coli Pathotypes. Frontiers in Medicine. 9. 829467–829467. 20 indexed citations

16.

Soltan, Mohamed A., Muhammad Alaa Eldeen, Eman Fayad, et al.. (2021). In Silico Designing of a Multitope Vaccine against Rhizopus microsporus with Potential Activity against Other Mucormycosis Causing Fungi. Cells. 10(11). 3014–3014. 28 indexed citations

17.

Eid, Refaat A., Attalla F. El‐kott, Samy M. Eleawa, et al.. (2020). Exendin-4 Ameliorates Cardiac Remodeling in Experimentally Induced Myocardial Infarction in Rats by Inhibiting PARP1/NF-κB Axis in A SIRT1-Dependent Mechanism. Cardiovascular Toxicology. 20(4). 401–418. 21 indexed citations

18.

Eid, Refaat A., Mashael Mohammed Bin-Meferij, Attalla F. El‐kott, et al.. (2020). Exendin-4 Protects Against Myocardial Ischemia-Reperfusion Injury by Upregulation of SIRT1 and SIRT3 and Activation of AMPK. Journal of Cardiovascular Translational Research. 14(4). 619–635. 67 indexed citations

19.

Eid, Refaat A., Attalla F. El‐kott, Mohamed Samir Ahmed Zaki, et al.. (2018). Acylated ghrelin protects aorta damage post-MI via activation of eNOS and inhibition of angiotensin-converting enzyme induced activation of NAD(P)H-dependent oxidase. Ultrastructural Pathology. 42(5). 416–429. 6 indexed citations

20.

Eid, Refaat A., Mohamed Samir Ahmed Zaki, Mubarak Al‐Shraim, et al.. (2018). Subacute ghrelin administration inhibits apoptosis and improves ultrastructural abnormalities in remote myocardium post-myocardial infarction. Biomedicine & Pharmacotherapy. 101. 920–928. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Babajan Banaganapalli Breakdown of academic impact, for papers by Huihui Guo Breakdown of academic impact, for papers by Ching-Yen Lin Breakdown of academic impact, for papers by Meizhou Huang Breakdown of academic impact, for papers by Naohisa Tsutsui Breakdown of academic impact, for papers by Nannan Liu Breakdown of academic impact, for papers by Yinhui Dong Breakdown of academic impact, for papers by Mengyuan Chen